TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 2898500

Group type: EXPERIMENTAL
Intervention: Chlorhexidine scrub (Hibiscrub-ICI)
Number of subjects: 375

Group type: COMPARATOR
Intervention: No chlorhexidine scrub
Number of subjects: 375

Group type: EXPERIMENTAL
Intervention: Chlorhexidine
Number of subjects: 375
Study: 31213445

Group type: EXPERIMENTAL
Intervention: Individualised risk-based variable-interval screening
Number of subjects: 4460

Group type: COMPARATOR
Intervention: Annual screening intervals
Number of subjects: 4460
Study: 27001007

Group type: EXPERIMENTAL
Intervention: Nicotine concentration in amniotic fluid
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Cotinine concentration in amniotic fluid
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Nicotine concentration in maternal saliva
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Cotinine concentration in maternal saliva
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Saliva cotinine concentration
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Time elapsed since last cigarette
Number of subjects: 42
Study: 25572008

Group type: EXPERIMENTAL
Intervention: nab-paclitaxel (100 mg/m2 weekly) plus carboplatin (C)
Number of subjects: 1038

Group type: COMPARATOR
Intervention: solvent-based paclitaxel (200 mg/m2 every 3 weeks) plus carboplatin (C)
Number of subjects: 1038
Study: 24236807

Group type: EXPERIMENTAL
Intervention: Self-efficacy coaching intervention (SCI)
Number of subjects: 65

Group type: COMPARATOR
Intervention: Attention control (AC)
Number of subjects: 65
Study: 21311897

Group type: EXPERIMENTAL
Intervention: Metoprolol controlled release/extended release (CR/XL) pretreatment
Number of subjects: 30

Group type: COMPARATOR
Intervention: Dobutamine stimulation
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Metoprolol CR/XL at low concentrations of dobutamine
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Metoprolol CR/XL at peak stress (40 μg/kg/min of dobutamine)
Number of subjects: 30
Study: 19037200

Group type: EXPERIMENTAL
Intervention: 100 mg modafinil
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (Met/Met genotype)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Modafinil and Val158Met polymorphism
Number of subjects: 0
Study: 17011057

Group type: EXPERIMENTAL
Intervention: Levosimendan infusion
Number of subjects: 0
Study: 15290425

Group type: EXPERIMENTAL
Intervention: 5% isoflurane (ISO group)
Number of subjects: 2

Group type: COMPARATOR
Intervention: 7% sevoflurane (SEV group)
Number of subjects: 2
Study: 11127498

Group type: EXPERIMENTAL
Intervention: Salbutamol via Easyhaler
Number of subjects: 32

Group type: COMPARATOR
Intervention: Salbutamol via Turbuhaler
Number of subjects: 32
Study: 10180369

Group type: EXPERIMENTAL
Intervention: Cheaper treatment
Number of subjects: 0

Group type: COMPARATOR
Intervention: More expensive treatment
Number of subjects: 0
Study: 8444537

Group type: EXPERIMENTAL
Intervention: Topical phenytoin
Number of subjects: 100

Group type: COMPARATOR
Intervention: Normal saline (control)
Number of subjects: 100
Study: 2944158

Group type: EXPERIMENTAL
Intervention: Local irradiation (45 Gy)
Number of subjects: 149

Group type: COMPARATOR
Intervention: Surgery only
Number of subjects: 149
Study: 29895280

Group type: EXPERIMENTAL
Intervention: Health Education (HE)
Number of subjects: 221

Group type: EXPERIMENTAL
Intervention: Motivational Interviewing (MI)
Number of subjects: 221

Group type: EXPERIMENTAL
Intervention: Brief Advice (BA)
Number of subjects: 221
Study: 27529765

Group type: EXPERIMENTAL
Intervention: 8-hour time in bed (TIB)
Number of subjects: 68

Group type: COMPARATOR
Intervention: 6-hour TIB with a 2-hour bedtime delay (late bedtime)
Number of subjects: 68

Group type: COMPARATOR
Intervention: 6-hour TIB with a 2-hour rise time advance (early rise time)
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: 8-hour TIB
Number of subjects: 68
Study: 24472633

Group type: EXPERIMENTAL
Intervention: Disease and care management (D&CM) intervention
Number of subjects: 762

Group type: COMPARATOR
Intervention: Usual-care (Control)
Number of subjects: 762
Study: 22388601

Group type: EXPERIMENTAL
Intervention: Intervention Group (IG) - Pharmacist involvement in drug therapy management, including targeted drug counselling before discharge.
Number of subjects: 77

Group type: COMPARATOR
Intervention: Control Group (CG) - Usual care without pharmacist involvement.
Number of subjects: 77
Study: 20439832

Group type: EXPERIMENTAL
Intervention: Active rTMS
Number of subjects: 199

Group type: COMPARATOR
Intervention: Sham rTMS
Number of subjects: 199
Study: 18714239

Group type: COMPARATOR
Intervention: Serial CE (concurrent exercise)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Integrated CE (concurrent exercise)
Number of subjects: 28
Study: 16184458

Group type: EXPERIMENTAL
Intervention: Complex decongestive physiotherapy (CDP) including lymph drainage, multi layer compression bandage, elevation, remedial exercises and skin care
Number of subjects: 53

Group type: COMPARATOR
Intervention: Standard physiotherapy (SP) including bandage, elevation, head-neck and shoulder exercises and skin care
Number of subjects: 53
Study: 12515747

Group type: EXPERIMENTAL
Intervention: Intravenous levosimendan (Levo)
Number of subjects: 146

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 146
Study: 11269973

Group type: EXPERIMENTAL
Intervention: Antineutrophil cytoplasmic antibodies (ANCAs) in IBD patients
Number of subjects: 75

Group type: COMPARATOR
Intervention: Control group (functional bowel disease)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: ANCA-positive IBD patients
Number of subjects: 75
Study: 8936353

Group type: EXPERIMENTAL
Intervention: Sinemet CR (50/200 mg carbidopa/mg levodopa)
Number of subjects: 170

Group type: COMPARATOR
Intervention: Sinemet STD (25/100 mg)
Number of subjects: 170
Study: 1587068

Group type: EXPERIMENTAL
Intervention: 2 mg alprazolam
Number of subjects: 24
Study: 4027151

Group type: EXPERIMENTAL
Intervention: Nicardipine
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 31385029

Group type: EXPERIMENTAL
Intervention: Heavy-loaded wrist flexor training (4 sets of 6-8 repetitions at 80% of 1-RM)
Number of subjects: 18
Study: 28299536

Group type: EXPERIMENTAL
Intervention: Readiness for RTW scale (Prepared for action - self-evaluative and Prepared for action - behavioral dimensions)
Number of subjects: 217

Group type: EXPERIMENTAL
Intervention: Readiness for RTW scale (Uncertain maintenance dimension)
Number of subjects: 217

Group type: COMPARATOR
Intervention: Expectation question about length of sick leave
Number of subjects: 217
Study: 27113592

Group type: EXPERIMENTAL
Intervention: Definitive chemoradiotherapy
Number of subjects: 21

Group type: COMPARATOR
Intervention: Chemoradiotherapy and surgery
Number of subjects: 21
Study: 25185135

Group type: EXPERIMENTAL
Intervention: Insured adults
Number of subjects: 0

Group type: COMPARATOR
Intervention: Uninsured adults
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Publicly insured adults
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Privately insured adults
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Visit frequency
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Statin therapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Healthcare insurance
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Poverty index
Number of subjects: 0
Study: 22914470

Group type: EXPERIMENTAL
Intervention: Robotic laparoscopic hysterectomy
Number of subjects: 100

Group type: COMPARATOR
Intervention: Conventional laparoscopic hysterectomy
Number of subjects: 100
Study: 20156500

Group type: EXPERIMENTAL
Intervention: Healthy beverage with health claims
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: Healthy beverage without health claims
Number of subjects: 108

Group type: COMPARATOR
Intervention: Less-healthy beverage with increased price
Number of subjects: 108

Group type: COMPARATOR
Intervention: Less-healthy beverage without increased price
Number of subjects: 108
Study: 19378514

Group type: EXPERIMENTAL
Intervention: Continuous infusion of remifentanil (RG)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Continuous infusion of sufentanil (SG)
Number of subjects: 60
Study: 15838691

Group type: EXPERIMENTAL
Intervention: PET/CT
Number of subjects: 32
Study: 11165726

Group type: EXPERIMENTAL
Intervention: β-blocker therapy in pregnancy (meta-analysis of trials)
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: β-blocker therapy in pregnancy (prospective cohort)
Number of subjects: 72
Study: 9491824

Group type: EXPERIMENTAL
Intervention: Intravenous ARTS (120 mg)
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Oral ARTS (100 mg)
Number of subjects: 26
Study: 7933735

Group type: EXPERIMENTAL
Intervention: Argatroban
Number of subjects: 17

Group type: COMPARATOR
Intervention: Low-dose heparin
Number of subjects: 17

Group type: COMPARATOR
Intervention: Untreated
Number of subjects: 17
Study: 2826285

Group type: EXPERIMENTAL
Intervention: Multiple hepatic arterial embolizations
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Hepatic arterial embolization once + monthly chemotherapy with high doses of 5‐fluorouracil
Number of subjects: 63

Group type: COMPARATOR
Intervention: Monthly chemotherapy with high doses of 5‐fluorouracil
Number of subjects: 63
Study: 2024656

Group type: EXPERIMENTAL
Intervention: Calcium acetate (initial dose 8.11 mmol (325 mg Ca2+) per meal, adjusted to 14.6 mmol (586 mg) Ca2+ per meal)
Number of subjects: 91

Group type: COMPARATOR
Intervention: Calcium acetate
Number of subjects: 91
Study: 319141

Group type: EXPERIMENTAL
Intervention: Methylprednisolone (steroids)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 31416212

Group type: EXPERIMENTAL
Intervention: Cardiose® (500 mg of 2S‐Hesperidin)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study: 28328790

Group type: EXPERIMENTAL
Intervention: Quetiapine XR
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Lithium
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 0
Study: 25602164

Group type: EXPERIMENTAL
Intervention: HMLE capsules
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo capsules
Number of subjects: 50
Study: 24851570

Group type: EXPERIMENTAL
Intervention: Oatmeal (70 g daily, 3 g beta-glucan)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Rice porridge (control product, 70 g daily)
Number of subjects: 24
Study: 20847731

Group type: EXPERIMENTAL
Intervention: Five feedings
Number of subjects: 35

Group type: COMPARATOR
Intervention: Three feedings
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Ice cream intake/kg
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Pre-ice cream fullness
Number of subjects: 35
Study: 19217691

Group type: EXPERIMENTAL
Intervention: 585-nm pulsed dye laser (PDL)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: 1064-nm Nd:YAG laser
Number of subjects: 18
Study: 17208269

Group type: EXPERIMENTAL
Intervention: High duty cycle tracking performance
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Low duty cycle tracking performance
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Ambiguous apparent motion display
Number of subjects: 0
Study: 15860518

Group type: EXPERIMENTAL
Intervention: G‐CSF (5 microg/kg/day s.c. for 4 consecutive days)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 11930719

Group type: EXPERIMENTAL
Intervention: Dyract Cement
Number of subjects: 75

Group type: COMPARATOR
Intervention: 3M‐Vitremer
Number of subjects: 75
Study: 9337376

Group type: EXPERIMENTAL
Intervention: Quadrivalent rotavirus vaccine (4x10^5 plaque-forming units per dose)
Number of subjects: 2207

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2207
Study: 8201908

Group type: EXPERIMENTAL
Intervention: Resistance training (3 sets of 7-11 repetitions of bicep curls with dumbbells, three times per week for 8 weeks)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Resistance training
Number of subjects: 16

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 16
Study: 2954736

Group type: EXPERIMENTAL
Intervention: Verapamil (240 mg/day)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Isradipine (15 mg/day)
Number of subjects: 24
Study: 29587697

Group type: EXPERIMENTAL
Intervention: Self-reported skirt size (SS) ≥ 18 when aged in 20s
Number of subjects: 94124

Group type: EXPERIMENTAL
Intervention: Self-reported skirt size (SS) ≥ 18 at questionnaire completion
Number of subjects: 94124

Group type: EXPERIMENTAL
Intervention: No change in skirt size (SS)
Number of subjects: 94124

Group type: EXPERIMENTAL
Intervention: Increase in skirt size (SS)
Number of subjects: 94124
Study: 28339794

Group type: EXPERIMENTAL
Intervention: Dabigatran (110 mg bid)
Number of subjects: 611

Group type: EXPERIMENTAL
Intervention: Dabigatran (150 mg bid)
Number of subjects: 611

Group type: COMPARATOR
Intervention: Warfarin (with heparin bridging)
Number of subjects: 611

Group type: COMPARATOR
Intervention: Warfarin (without heparin bridging)
Number of subjects: 611
Study: 26223232

Group type: EXPERIMENTAL
Intervention: Stepped implementation strategy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Breakthrough strategy (Control)
Number of subjects: 0
Study: 23839984

Group type: EXPERIMENTAL
Intervention: Breastfeeding with skin-to-skin contact (BF+SSC Group)
Number of subjects: 136

Group type: EXPERIMENTAL
Intervention: Sucrose with skin-to-skin contact (Sucrose+SSC Group)
Number of subjects: 136

Group type: COMPARATOR
Intervention: Skin-to-skin contact (SSC Group)
Number of subjects: 136

Group type: COMPARATOR
Intervention: Sucrose (Sucrose Group)
Number of subjects: 136
Study: 21443837

Group type: EXPERIMENTAL
Intervention: Anticoagulation with 40 mg of enoxaparin subcutaneously once daily for 21 days
Number of subjects: 29

Group type: COMPARATOR
Intervention: No postoperative anticoagulation
Number of subjects: 29
Study: 18493597

Group type: EXPERIMENTAL
Intervention: Intermittent preventive treatment (IPTi) using sulfadoxine-pyrimethamine (SP)
Number of subjects: 2485
Study: 16574171

Group type: EXPERIMENTAL
Intervention: Functional Energy Drink (FED)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Non Functional Energy Drink (NonFED)
Number of subjects: 15
Study: 12679453

Group type: EXPERIMENTAL
Intervention: Continue GH therapy (0.35 IU/kg x wk)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Discontinue GH therapy
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Continue GH therapy
Number of subjects: 24
Study: 11726895

Group type: EXPERIMENTAL
Intervention: HeartMate Vented Electric Left Ventricular Assist System (VE LVAS)
Number of subjects: 280

Group type: COMPARATOR
Intervention: Control group (not supported with LVAS)
Number of subjects: 280
Study: 9144037

Group type: EXPERIMENTAL
Intervention: Take Heart II intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study: 8181239

Group type: EXPERIMENTAL
Intervention: Fluoxetine 60 mg daily
Number of subjects: 19

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19
Study: 2905372

Group type: EXPERIMENTAL
Intervention: Teicoplanin
Number of subjects: 118

Group type: COMPARATOR
Intervention: Flucloxacillin and tobramycin
Number of subjects: 118
Study: 31597555

Group type: EXPERIMENTAL
Intervention: Telephone-based self-help cognitive behavioural therapy (tel-CBT)
Number of subjects: 13
Study: 29044032

Group type: EXPERIMENTAL
Intervention: Vitamin D levels higher than 50 nmol/L
Number of subjects: 159

Group type: COMPARATOR
Intervention: Vitamin D deficiency (lower than 37.5 nmol/L)
Number of subjects: 159
Study: 25781481

Group type: EXPERIMENTAL
Intervention: Extensively hydrolysed casein-based formula (eHCF)
Number of subjects: 119

Group type: COMPARATOR
Intervention: Probiotic supplementation
Number of subjects: 119
Study: 23597811

Group type: EXPERIMENTAL
Intervention: Pre-sliced fruit (apples) served in treatment schools
Number of subjects: 0

Group type: COMPARATOR
Intervention: Whole apples served in control schools
Number of subjects: 0
Study: 21678741

Group type: EXPERIMENTAL
Intervention: DTaP-IPV//PRP T vaccine (Pentaxim)
Number of subjects: 212
Study: 19702617

Group type: EXPERIMENTAL
Intervention: High-intensity functional weight-bearing exercise program
Number of subjects: 191

Group type: COMPARATOR
Intervention: Control activity
Number of subjects: 191
Study: 16738507

Group type: EXPERIMENTAL
Intervention: Hyperventilation with increased tidal volume
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Hyperventilation with increased respiratory rate
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Hypoventilation by decreased respiratory rate
Number of subjects: 10
Study: 15172704

Group type: EXPERIMENTAL
Intervention: Active impedance threshold device (ITD)
Number of subjects: 400

Group type: COMPARATOR
Intervention: Sham valve
Number of subjects: 400
Study: 10970701

Group type: EXPERIMENTAL
Intervention: Early vaccination with several doses of Hib vaccine starting at three months
Number of subjects: 114000

Group type: COMPARATOR
Intervention: Late vaccination with a single dose of Hib vaccine at two years
Number of subjects: 114000
Study: 8874564

Group type: EXPERIMENTAL
Intervention: Adenosine infusion (80 micrograms.kg-1.min-1)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study: 1394219

Group type: EXPERIMENTAL
Intervention: Exemestane (FCE 24304) 25 mg
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Exemestane (FCE 24304) 50 mg
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Exemestane (FCE 24304) 200 mg
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Exemestane (FCE 24304) 400 mg
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Exemestane (FCE 24304) 800 mg
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Exemestane (FCE 24304) (all doses)
Number of subjects: 29
Study: 3903778

Group type: EXPERIMENTAL
Intervention: 1000 mg naproxen
Number of subjects: 50

Group type: COMPARATOR
Intervention: 20 mg piroxicam
Number of subjects: 50
Study: 31870413

Group type: COMPARATOR
Intervention: Immediate prescription for antibiotics
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Immediate prescription for antibiotics plus a 7-day course of cranberry capsules
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Cranberry capsules plus a delayed prescription for antibiotics
Number of subjects: 45
Study: 29426699

Group type: EXPERIMENTAL
Intervention: Lipid-enriched enteral tube feeding from 3 h before until 6 h after surgery
Number of subjects: 265

Group type: COMPARATOR
Intervention: Standard care (no perioperative nutrition)
Number of subjects: 265
Study: 26990685

Group type: EXPERIMENTAL
Intervention: Huddling programme (full-day retreat and after-work social networking services)
Number of subjects: 49

Group type: COMPARATOR
Intervention: Control group (not specified in detail)
Number of subjects: 49
Study: 24937967

Group type: EXPERIMENTAL
Intervention: Vaginal progesterone gel supplementation (study group, n = 71)
Number of subjects: 149

Group type: COMPARATOR
Intervention: No drug for luteal support (control group, n = 78)
Number of subjects: 149
Study: 22320449

Group type: EXPERIMENTAL
Intervention: Early treatment with almotriptan
Number of subjects: 0

Group type: COMPARATOR
Intervention: Non-early treatment
Number of subjects: 0
Study: 20185669

Group type: EXPERIMENTAL
Intervention: Pressure pain thresholds (PPT) assessment at cervical zygapophysial joints
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Pressure pain thresholds (PPT) assessment with cutoff of 1 kPa
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Pressure pain thresholds (PPT) assessment with cutoff of 30 kPa
Number of subjects: 33

Group type: COMPARATOR
Intervention: Comparison of PPT between patients and pain-free subjects
Number of subjects: 33
Study: 17950147

Group type: EXPERIMENTAL
Intervention: Iron sucrose complex, 200 mg weekly for 5 weeks
Number of subjects: 40

Group type: COMPARATOR
Intervention: Isotonic saline solution
Number of subjects: 40
Study: 16253504

Group type: EXPERIMENTAL
Intervention: Dydrogesterone (10 mg b.i.d.)
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Intramuscular human chorionic gonadotrophin (hCG; 5000 IU every 4 days)
Number of subjects: 180

Group type: COMPARATOR
Intervention: No additional treatment (controls)
Number of subjects: 180
Study: 12003054

Group type: EXPERIMENTAL
Intervention: Recombinant Interferon-2alpha
Number of subjects: 0
Study: 9988780

Group type: EXPERIMENTAL
Intervention: MCT oil (71 g)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Canola oil (71 g)
Number of subjects: 20
Study: 9464324

Group type: EXPERIMENTAL
Intervention: HDR brachytherapy for cervical cancer
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: HDR brachytherapy for tongue cancer
Number of subjects: 0

Group type: COMPARATOR
Intervention: MDR brachytherapy for cervical cancer
Number of subjects: 0

Group type: COMPARATOR
Intervention: LDR brachytherapy for tongue cancer
Number of subjects: 0
Study: 1765893

Group type: EXPERIMENTAL
Intervention: Behaviorally based smoking-cessation program with methadone dose increase
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (placebo)
Number of subjects: 0
Study: 6416511

Group type: EXPERIMENTAL
Intervention: Human insulin
Number of subjects: 21

Group type: COMPARATOR
Intervention: Porcine insulin
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Both treatments
Number of subjects: 21
Study: 30838899

Group type: EXPERIMENTAL
Intervention: Hypotension control
Number of subjects: 10000
Study: 30103776

Group type: EXPERIMENTAL
Intervention: Interaction Competencies with Children for Teachers (ICC-T)
Number of subjects: 60

Group type: COMPARATOR
Intervention: No intervention (control)
Number of subjects: 60
Study: 27318807

Group type: EXPERIMENTAL
Intervention: CRT-D
Number of subjects: 534

Group type: COMPARATOR
Intervention: ICD-only
Number of subjects: 534
Study: 24888732

Group type: EXPERIMENTAL
Intervention: Curriculum intervention using a pedagogical communication strategy
Number of subjects: 300

Group type: COMPARATOR
Intervention: Wait-list control group
Number of subjects: 300
Study: 23032060

Group type: EXPERIMENTAL
Intervention: Insulin infusion at three progressively higher rates (approximately 150, 350, and 700 pmol/liter) during hyperglycemia (glucose maintained at approximately 9 mmol/liter)
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Insulin infusion
Number of subjects: 2
Study: 20547942

Group type: EXPERIMENTAL
Intervention: Topical voriconazole
Number of subjects: 120

Group type: COMPARATOR
Intervention: Scraping
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Topical voriconazole (in patients with baseline BSCVA of 20/40 to 20/400)
Number of subjects: 120
Study: 18580347

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (1 microg/kg) intravenously over 10 minutes before induction of anesthesia
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo (saline)
Number of subjects: 40